ConductScience.org, home

Paper40944804

Tumor microenvironment response to neoadjuvant therapy in breast cancer: insights from single-cell and spatial omics.

Wu Q and 5 others. Med Oncol, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Tumor microenvironment response to neoadjuvant therapy in breast cancer: insights from single-cell and spatial omics. Papers, record 40944804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40944804

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor microenvironment response to neoadjuvant therapy in breast cancer: insights from single-cell and spatial omics.
PubMed
Journal
Med Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-11-05
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu QQingzhong
2Yang JJiawei
3Zhang DDa
4Xu HHaowei
5Yu YYuhang
6Zheng YYu

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
Breast NeoplasmsMajor topic
Neoadjuvant TherapyMajor topic
Single-Cell AnalysisMajor topic
Humans
Female

References150

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129126881Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents.Biochim Biophys Acta Rev Cancer2018https://conductscience.org/library/papers/29126881PubMed
225214542The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.Ann Oncol2015https://conductscience.org/library/papers/25214542PubMed
340102282Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies.Med Oncol2025https://conductscience.org/library/papers/40102282PubMed
436869384Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing.Genome Med2023https://conductscience.org/library/papers/36869384PubMed
534579743Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34579743PubMed
637278484Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2-negative breast cancer.Cancer Commun (Lond)2023https://conductscience.org/library/papers/37278484PubMed
737947371Revolutionizing the battle against locally advanced breast cancer: A comprehensive insight into neoadjuvant radiotherapy.Med Res Rev2024https://conductscience.org/library/papers/37947371PubMed
835501486A T cell resilience model associated with response to immunotherapy in multiple tumor types.Nat Med2022https://conductscience.org/library/papers/35501486PubMed
934966897Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response.Nat Cancer2021https://conductscience.org/library/papers/34966897PubMed
1033334813Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk.Cancer Res2021https://conductscience.org/library/papers/33334813PubMed
1131710162Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.Cancer Sci2020https://conductscience.org/library/papers/31710162PubMed
1229674477Blockade of Myeloid-Derived Suppressor Cell Expansion with All-Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy.Cancer Res2018https://conductscience.org/library/papers/29674477PubMed
1322788954Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.Breast Cancer Res2012https://conductscience.org/library/papers/22788954PubMed
1427939063Molecular alterations in triple-negative breast cancer-the road to new treatment strategies.Lancet2017https://conductscience.org/library/papers/27939063PubMed
1538614094A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response.Cell Rep Med2024https://conductscience.org/library/papers/38614094PubMed
1632086381Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics.Sci Immunol2020https://conductscience.org/library/papers/32086381PubMed
1730927930Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer.Mol Cancer2019https://conductscience.org/library/papers/30927930PubMed
1839522613Estrogens and breast cancer.Ann Oncol2025https://conductscience.org/library/papers/39522613PubMed
1939875975CXCR4 promotes tumor stemness maintenance and CDK4/6 inhibitors resistance in ER-positive breast cancer.Breast Cancer Res2025https://conductscience.org/library/papers/39875975PubMed
2032460816Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer.Breast Cancer Res2020https://conductscience.org/library/papers/32460816PubMed

See all 150 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41379384Integrating tumor microenvironment insights into neoadjuvant strategies.Med Oncol2025https://conductscience.org/library/papers/41379384

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40944804

GET https://conductscience.org/api/papers/v1/40944804/references?page=2